DUBLIN, IRELAND -- (Marketwired) -- Research and Markets (http://www.researchandmarkets.com/research/kpskz3/pointofcare) has announced the addition of the "Point-Of-Care Diagnostic Market by Products, End Users, Over the Counter & Prescription Based - Global Forecast to 2018" report to their offering.
The global POC diagnostics market has been segmented on the basis of category (infectious diseases testing kits, glucose monitoring kits, cardiac markers, pregnancy and fertility testing kits, and others) and end users (patient professional monitoring kits and patient self-monitoring kits). The glucose monitoring kits market held the largest share - 53.7% - of the global POC diagnostics market in 2013, followed by the infectious diseases testing kits market. Factors such as rising global prevalence of diabetes, technological advancements in self-monitoring of blood glucose, and the growing patient awareness toward POC testing are stimulating the growth of the glucose monitoring kits market.
The fastest-growing segment - cardiac-markers market - is projected to grow at a CAGR of 15.3% from 2013 to 2018. This growth is mainly attributed to the increasing number of cardiac patients and the demand of immediate diagnosis of the diseases. Major players such as Roche (Switzerland), Abbott Laboratories, Inc. (U.S.), Siemens AG (Germany), Beckman Coulter, Inc. (U.S.), and Alere Inc. (U.S.) are adopting several growth strategies such as new product launches, partnerships, agreements, collaborations, joint ventures, and mergers and acquisition in order to keep pace with the evolving industry trends.
The global POC diagnostics market is highly competitive with a large number of global as well as local market players. As of 2012, the global POC diagnostics market excluding the blood glucose monitoring kits market was dominated by Roche (Switzerland), Alere Inc. (U.S.), Siemens AG (Germany), and Beckman Coulter, Inc. (U.S.), which together accounted for -72% of the market. New product launches and partnerships/agreements/collaborations/joint ventures are the major strategies adopted by most market players to achieve growth in the POC diagnostics market.
Scope of the Report
-- Infectious Diseases Testing Kits -- Glucose Monitoring Kits -- Coagulation Monitoring Kits -- Urinalysis Testing Kits -- Hematology Testing Kits -- Cholesterol Test Strips -- Drugs of Abuse Testing Kits -- Cardiac Markers -- Blood Gas/Electrolytes Testing Kits -- Tumor/Cancer Markers -- Pregnancy and Fertility Testing Kits -- Fecal Occult Testing Kits -- Food Pathogens Testing Kits -- Others
-- Over-the-counter (OTC) Testing Kits -- Prescription-based Testing Kits
-- Professional Monitoring Kits -- Patients Self-Monitoring Kits
Key Topics Covered:
2 Executive Summary
3 Premium Insights
4 Market Overview
5 Industry Trends
6 Point-Of-Care Diagnostics Market, By Product
7 Point-Of-Care Diagnostics Market, By Prescription Mode
8 Point-Of-Care Diagnostics Market, By End User
9 Point-Of-Care Diagnostics Market, By Geography
10 Competitive Landscape
11 Company Profiles
-- Abaxis, Inc. -- Abbott Laboratories, Inc. -- Alere, Inc. -- Bayer Healthcare Ag -- Beckman Coulter, Inc. -- Becton, Dickinson And Company -- Johnson & Johnson -- Nipro Diagnostics, Inc. -- Roche Diagnostics Limited -- Siemens Healthcare
For more information visit http://www.researchandmarkets.com/research/kpskz3/pointofcare
Sector: Point-of-Care Diagnostics
Contacts: Research and Markets Laura Wood, Senior Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-415-1241 Research and Markets U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716